Literature DB >> 11603784

Metabotropic transmitter actions in auditory thalamus.

D W Schwarz1, F Tennigkeit, E Puil.   

Abstract

Neurons in the ventral partition of the medial geniculate body (MGBv), the primary auditory thalamus, receive afferent input from the inferior colliculus via excitatory glutamate-ergic and inhibitory GABA-ergic input fibres. The feedback from the auditory cortex to the thalamic relay also is mediated via neuron systems using glutamate and GABA as transmitters. We studied effects on excitability mediated by these transmitters via G-protein coupled metabotropic receptors. In a slice preparation of rat thalamus we investigated the membrane responses of MGBv neurons using the whole cell recording technique. Application of a metabotropic glutamate receptor (mGluR) agonist, ACPD (5-100 microM), depolarized MGBv neurons. As a result, the burst mode of firing, which characterizes states of sleep at hyperpolarized potentials was replaced by the tonic mode, which is compatible with sound signal transmission during alertness. The depolarization was caused by an inward current (I(ACPD)) that persisted during blockade of Na+ channels with tetrodotoxin (TTX) and of Ca2+ channels with Cd2+. The I(ACPD) depended, however, on extracellular Na+, which could be replaced with Li+, excluding a major contribution of the Na+/Ca2+ exchange current. ACPD application also inhibited an inwardly rectifying K+ current at hyperpolarized potentials and activated an outward current in the depolarized range. Application of the GABA(B) agonist, baclofen (10 microM), hyperpolarized MGBv neurons by activation of an inwardly rectifying K+ current. The corresponding membrane conductance acted as a powerful shunt that reduced voltage responses and inhibited firing in both the tonic and burst modes. Thus, the effects of GABA(B) receptor activation would suppress auditory signal transfer, whereas mGluR activation enhances excitability, possibly accounting for the alerting effects of certain auditory stimuli.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11603784     DOI: 10.1080/000164800750001035

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  8 in total

Review 1.  Neuromodulation in the spiral ganglion: shaping signals from the organ of corti to the CNS.

Authors:  D Dulon; D J Jagger; X Lin; R L Davis
Journal:  J Membr Biol       Date:  2006-05-25       Impact factor: 1.843

Review 2.  Synchronicity in the performing arts: Oscar Wilde's nightmare?

Authors:  G J F de Haas
Journal:  Clin Rheumatol       Date:  2013-02-17       Impact factor: 2.980

3.  Anatomy and Physiology of Metabotropic Glutamate Receptors in Mammalian and Avian Auditory System.

Authors:  Zheng-Quan Tang; Yong Lu
Journal:  HSOA Trends Anat Physiol       Date:  2018-02-09

Review 4.  Metabotropic glutamate receptors in auditory processing.

Authors:  Y Lu
Journal:  Neuroscience       Date:  2014-06-05       Impact factor: 3.590

5.  Glutamate regulates the frequency of spontaneous synchronized Ca2+ spikes through group II metabotropic glutamate receptor in cultured mouse cortical networks.

Authors:  Fumie Yasumoto; Takayuki Negishi; Yoshiyuki Ishii; Shigeru Kyuwa; Yoichiro Kuroda; Yasuhiro Yoshikawa
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

6.  Theta, alpha and beta burst transcranial magnetic stimulation: brain modulation in tinnitus.

Authors:  Dirk De Ridder; Elsa van der Loo; Karolien Van der Kelen; Tomas Menovsky; Paul van de Heyning; Aage Moller
Journal:  Int J Med Sci       Date:  2007-10-09       Impact factor: 3.738

Review 7.  Mechanisms of GABAergic and cholinergic neurotransmission in auditory thalamus: Impact of aging.

Authors:  B D Richardson; S Y Sottile; D M Caspary
Journal:  Hear Res       Date:  2020-06-11       Impact factor: 3.672

8.  Transcranial magnetic stimulation for the treatment of tinnitus: effects on cortical excitability.

Authors:  Berthold Langguth; Tobias Kleinjung; Joerg Marienhagen; Harald Binder; Philipp G Sand; Göran Hajak; Peter Eichhammer
Journal:  BMC Neurosci       Date:  2007-07-02       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.